Why the study?
Does admission glycosylated hemoglobin level predict mortality, congestive heart failure, and shock in patients with acute ST-segment elevation myocardial infarction?
Does admission glycosylated hemoglobin level predict mortality, congestive heart failure, and shock in patients with acute ST-segment elevation myocardial infarction?
Answers are grounded in this paper and cite their sources.
The text highlights the need to evaluate the prognostic value of admission glycosylated hemoglobin in STEMI patients treated with primary PCI, as previous evidence is mainly derived from fibrinolytic therapy trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Elfawal et al. (2018) studied Acute ST-segment elevation myocardial infarction. Admission glycosylated hemoglobin level was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: